Scholarlink

Background <p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly worldwide since its emergence in 2019. While infections in children are generally mild, severe disease can occur in some rare cases. Herein, we aim to identify risk factors for severe disease in children hospitalized with SARS-CoV-2 infection during the post-Omicron period.</p> Methods <p>This retrospective cohort study was based on a review of the records of children aged under 15 years hospitalized with SARS-CoV-2 infection at a university hospital in Xi’an, China between December 8, 2022, and January 17, 2023. Multivariable logistic regression was applied to identify factors associated with severe disease.</p> Results <p>Of 164 children included in the analysis, 33 had severe disease and 131 had non-severe disease. Disease severity did not differ significantly according to sex or SARS-CoV-2 vaccination status. The prevalence of comorbidities was significantly higher in children with severe disease than in those with non-severe disease (30% [10/33] vs. 10.7% [14/131], <i>p</i> = 0.04). The prevalence of neurological manifestations and multisystem disease were also significantly higher in children with severe disease than in those with non-severe disease (91% [30/33] vs. 27.5% [36/131], <i>p</i> = 0.001; and 64% [21/33] vs. 43.5% [57/131], <i>p</i> = 0.039, respectively). Multivariable logistic regression analysis identified younger age (odds ratio [OR]: 0.702, 95% confidence interval [CI]: 0.551–0.893; <i>p</i> = 0.004), the presence of comorbidities (OR: 9.042, 95% CI: 2.505X–32.645; <i>p</i> = 0.001), and neurological signs (OR: 217.21, 95% CI: 34.988–1348.469; <i>p</i> &lt; 0.001) as independent risk factors for severe disease.</p> Conclusion <p>This single-center retrospective cohort study reveals that younger children with comorbidities and neurological manifestations are at higher risk of developing severe SARS-CoV-2 infection. These findings should be interpreted considering limitations including short study timeframe, homogeneous vaccine types, and lack of variant-specific analyses.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risk factors for severe disease in children hospitalized with SARS-CoV-2 infection in China: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月18日

查看全文
  • Yan Wang,
  • Ye Song,
  • Binhui Zhu,
  • You Feng,
  • Dandan Lou,
  • Yueping Zhang

摘要

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly worldwide since its emergence in 2019. While infections in children are generally mild, severe disease can occur in some rare cases. Herein, we aim to identify risk factors for severe disease in children hospitalized with SARS-CoV-2 infection during the post-Omicron period.

Methods

This retrospective cohort study was based on a review of the records of children aged under 15 years hospitalized with SARS-CoV-2 infection at a university hospital in Xi’an, China between December 8, 2022, and January 17, 2023. Multivariable logistic regression was applied to identify factors associated with severe disease.

Results

Of 164 children included in the analysis, 33 had severe disease and 131 had non-severe disease. Disease severity did not differ significantly according to sex or SARS-CoV-2 vaccination status. The prevalence of comorbidities was significantly higher in children with severe disease than in those with non-severe disease (30% [10/33] vs. 10.7% [14/131], p = 0.04). The prevalence of neurological manifestations and multisystem disease were also significantly higher in children with severe disease than in those with non-severe disease (91% [30/33] vs. 27.5% [36/131], p = 0.001; and 64% [21/33] vs. 43.5% [57/131], p = 0.039, respectively). Multivariable logistic regression analysis identified younger age (odds ratio [OR]: 0.702, 95% confidence interval [CI]: 0.551–0.893; p = 0.004), the presence of comorbidities (OR: 9.042, 95% CI: 2.505X–32.645; p = 0.001), and neurological signs (OR: 217.21, 95% CI: 34.988–1348.469; p < 0.001) as independent risk factors for severe disease.

Conclusion

This single-center retrospective cohort study reveals that younger children with comorbidities and neurological manifestations are at higher risk of developing severe SARS-CoV-2 infection. These findings should be interpreted considering limitations including short study timeframe, homogeneous vaccine types, and lack of variant-specific analyses.